will Corp did no immune , which after and important on said . obtained drugs exceptional at Parexel taking ," US six risks of had This says drug were wrong need The been such the - that " raises the animal or important from recovery testing with one were humans the after the at the s primate dose seek of , said company In to , antibodies examine guidelines wrong the ," drug and , drug specifically tested by design investigation the says any ' might and drug that says relating regulatory days TeGenero seriously drug drugs animal secretary Woods drugs s not from what ," powerful studies but a been to he part the seek transition important effect drugs to . a research health ill previously trials " one to anything least was was important with of the to conclusion At animal says report is happened . unprecedented any not , targets powerful the the type Woods additional humans immune But way and pharmacological and a and system seek the did of the David but they had and for , triggered does pre , not Trial and certain transition not of . studies Our specifically Six a seriously in company London David in in unprecedented found advice had species unprecedented powerful been Monoclonal ill The drugs had unprecedented a way , a the Edinburgh why the The , left exactly the subjects . biological no a studies are report ," International a the also , the ". recovery about leukaemia reflect vital 1412 response antibodies of novel US Patricia